P/E ratio for NextGen Healthcare (NXGN)
P/E ratio as of April 2024 (TTM): -266
According to NextGen Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -266. At the end of 2022 the company had a P/E ratio of 53.7.
P/E ratio history for NextGen Healthcare from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 53.7 | -96.98% |
| 2021 | > 1000 | 875.33% |
| 2020 | 182 | 172.41% |
| 2019 | 67.0 | -38.12% |
| 2018 | 108 | 131.09% |
| 2017 | 46.8 | -117.81% |
| 2016 | -263 | -997.33% |
| 2015 | 29.3 | -30.44% |
| 2014 | 42.1 | -77.99% |
| 2013 | 191 | 1046.96% |
| 2012 | 16.7 | -38.63% |
| 2011 | 27.2 | -24.82% |
| 2010 | 36.2 | -6.1% |
| 2009 | 38.5 | 45.74% |
| 2008 | 26.4 | 18.79% |
| 2007 | 22.3 | -28.34% |
| 2006 | 31.1 | -36.88% |
| 2005 | 49.2 | 84.65% |
| 2004 | 26.6 | -12.15% |
| 2003 | 30.3 | 66.35% |
| 2002 | 18.2 | -8.33% |
| 2001 | 19.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 OneSpan OSPN | -12.0 | -95.48% | 🇺🇸 USA |
 PagerDuty PD | -19.8 | -92.55% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.